Transfer of Maternal Anti-Microbial Immunity to HIV-Exposed Uninfected Newborns

The transfer of maternal immune factors to the newborn is critical for protection from infectious disease in early life. Maternally acquired passive immunity provides protection until the infant is beyond early life’s increased susceptibility to severe infections, or until active immunity is achieve...

Full description

Bibliographic Details
Main Authors: Bahaa Abu Raya, Kinga Smolen, Fabienne Willems, Tobias Kollmann, Arnaud Marchant
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00338/full
_version_ 1818933483977834496
author Bahaa Abu Raya
Kinga Smolen
Fabienne Willems
Tobias Kollmann
Arnaud Marchant
author_facet Bahaa Abu Raya
Kinga Smolen
Fabienne Willems
Tobias Kollmann
Arnaud Marchant
author_sort Bahaa Abu Raya
collection DOAJ
description The transfer of maternal immune factors to the newborn is critical for protection from infectious disease in early life. Maternally acquired passive immunity provides protection until the infant is beyond early life’s increased susceptibility to severe infections, or until active immunity is achieved following infant’s primary immunization. However, as reviewed here, HIV infection alters the transfer of immune factors from HIV-infected mothers to the HIV-exposed newborns and young infants. This may relate to the immune activation in HIV-infected pregnant women, associated with the production of inflammatory cytokines at the materno-fetal interface associated with inflammatory responses in the newborn. We also summarize mother-targeting interventions to improve the health of infants born to HIV-infected women such as immunization during pregnancy and reduction of maternal inflammation. Maternal immunization offers the potential to compensate for the decreased transplacentally transferred maternal antibodies observed in HIV-exposed infants. Current data suggest reduced immunogenicity of vaccines in HIV-infected pregnant women, possibly reducing the protective impact of maternal immunization for HIV-exposed infants. Fortunately, levels of antibodies appear preserved in the breast milk of HIV-infected women, which supports the recommendation to breastfeed during antiretroviral treatment to protect HIV-exposed infants.
first_indexed 2024-12-20T04:49:06Z
format Article
id doaj.art-aed7cc44749e4a99905606f8265d6106
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-20T04:49:06Z
publishDate 2016-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-aed7cc44749e4a99905606f8265d61062022-12-21T19:52:55ZengFrontiers Media S.A.Frontiers in Immunology1664-32242016-08-01710.3389/fimmu.2016.00338218619Transfer of Maternal Anti-Microbial Immunity to HIV-Exposed Uninfected NewbornsBahaa Abu Raya0Kinga Smolen1Fabienne Willems2Tobias Kollmann3Arnaud Marchant4University of British ColumbiaUniversité Libre de BruxellesUniversité Libre de BruxellesUniversity of British ColumbiaUniversité Libre de BruxellesThe transfer of maternal immune factors to the newborn is critical for protection from infectious disease in early life. Maternally acquired passive immunity provides protection until the infant is beyond early life’s increased susceptibility to severe infections, or until active immunity is achieved following infant’s primary immunization. However, as reviewed here, HIV infection alters the transfer of immune factors from HIV-infected mothers to the HIV-exposed newborns and young infants. This may relate to the immune activation in HIV-infected pregnant women, associated with the production of inflammatory cytokines at the materno-fetal interface associated with inflammatory responses in the newborn. We also summarize mother-targeting interventions to improve the health of infants born to HIV-infected women such as immunization during pregnancy and reduction of maternal inflammation. Maternal immunization offers the potential to compensate for the decreased transplacentally transferred maternal antibodies observed in HIV-exposed infants. Current data suggest reduced immunogenicity of vaccines in HIV-infected pregnant women, possibly reducing the protective impact of maternal immunization for HIV-exposed infants. Fortunately, levels of antibodies appear preserved in the breast milk of HIV-infected women, which supports the recommendation to breastfeed during antiretroviral treatment to protect HIV-exposed infants.http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00338/fullCytokinesInflammationPlacentaPregnancyIgGNewborn
spellingShingle Bahaa Abu Raya
Kinga Smolen
Fabienne Willems
Tobias Kollmann
Arnaud Marchant
Transfer of Maternal Anti-Microbial Immunity to HIV-Exposed Uninfected Newborns
Frontiers in Immunology
Cytokines
Inflammation
Placenta
Pregnancy
IgG
Newborn
title Transfer of Maternal Anti-Microbial Immunity to HIV-Exposed Uninfected Newborns
title_full Transfer of Maternal Anti-Microbial Immunity to HIV-Exposed Uninfected Newborns
title_fullStr Transfer of Maternal Anti-Microbial Immunity to HIV-Exposed Uninfected Newborns
title_full_unstemmed Transfer of Maternal Anti-Microbial Immunity to HIV-Exposed Uninfected Newborns
title_short Transfer of Maternal Anti-Microbial Immunity to HIV-Exposed Uninfected Newborns
title_sort transfer of maternal anti microbial immunity to hiv exposed uninfected newborns
topic Cytokines
Inflammation
Placenta
Pregnancy
IgG
Newborn
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00338/full
work_keys_str_mv AT bahaaaburaya transferofmaternalantimicrobialimmunitytohivexposeduninfectednewborns
AT kingasmolen transferofmaternalantimicrobialimmunitytohivexposeduninfectednewborns
AT fabiennewillems transferofmaternalantimicrobialimmunitytohivexposeduninfectednewborns
AT tobiaskollmann transferofmaternalantimicrobialimmunitytohivexposeduninfectednewborns
AT arnaudmarchant transferofmaternalantimicrobialimmunitytohivexposeduninfectednewborns